Your browser doesn't support javascript.
loading
Prognostic value of HER2 status on circulating tumor cells in advanced-stage breast cancer patients with HER2-negative tumors.
Wang, Chun; Mu, Zhaomei; Ye, Zhong; Zhang, Zhenchao; Abu-Khalaf, Maysa M; Silver, Daniel P; Palazzo, Juan P; Jagannathan, Geetha; Fellin, Frederick M; Bhattacharya, Saveri; Jaslow, Rebecca J; Tsangaris, Theodore N; Berger, Adam; Neupane, Manish; Cescon, Terrence P; Lopez, AnaMaria; Yao, Kaelan; Chong, Weelic; Lu, Brian; Myers, Ronald E; Hou, Lifang; Wei, Qiang; Li, Bingshan; Cristofanilli, Massimo; Yang, Hushan.
Affiliation
  • Wang C; Department of Medical Oncology, Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA, 19107, USA.
  • Mu Z; Division of Hematology and Oncology, Department of Medicine, Robert H. Lurie Comprehensive Cancer Center, Feinberg School of Medicine, Northwestern University, Chicago, IL, 60611, USA.
  • Ye Z; Department of Medical Oncology, Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA, 19107, USA.
  • Zhang Z; Department of Medical Oncology, Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA, 19107, USA.
  • Abu-Khalaf MM; Department of Medical Oncology, Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA, 19107, USA.
  • Silver DP; Department of Medical Oncology, Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA, 19107, USA.
  • Palazzo JP; Department of Pathology, Thomas Jefferson University, Philadelphia, PA, 19107, USA.
  • Jagannathan G; Department of Pathology, Thomas Jefferson University, Philadelphia, PA, 19107, USA.
  • Fellin FM; Department of Medical Oncology, Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA, 19107, USA.
  • Bhattacharya S; Department of Medical Oncology, Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA, 19107, USA.
  • Jaslow RJ; Department of Medical Oncology, Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA, 19107, USA.
  • Tsangaris TN; Department of Medical Oncology, Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA, 19107, USA.
  • Berger A; Department of Surgery, Thomas Jefferson University, Philadelphia, PA, 19107, USA.
  • Neupane M; Department of Medical Oncology, Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA, 19107, USA.
  • Cescon TP; Department of Hematology Oncology, Reading Hospital, West Reading, PA, 19611, USA.
  • Lopez A; Department of Medical Oncology, Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA, 19107, USA.
  • Yao K; Department of Medical Oncology, Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA, 19107, USA.
  • Chong W; Department of Medical Oncology, Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA, 19107, USA.
  • Lu B; Department of Medical Oncology, Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA, 19107, USA.
  • Myers RE; Department of Medical Oncology, Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA, 19107, USA.
  • Hou L; Department of Preventive Medicine, Northwestern University, Chicago, IL, 60611, USA.
  • Wei Q; Department of Molecular Physiology and Biophysics, Vanderbilt University, Nashville, TN, 37235, USA.
  • Li B; Department of Molecular Physiology and Biophysics, Vanderbilt University, Nashville, TN, 37235, USA.
  • Cristofanilli M; Division of Hematology and Oncology, Department of Medicine, Robert H. Lurie Comprehensive Cancer Center, Feinberg School of Medicine, Northwestern University, Chicago, IL, 60611, USA. massimo.cristofanilli@nm.org.
  • Yang H; Department of Medical Oncology, Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA, 19107, USA. hushan.yang@jefferson.edu.
Breast Cancer Res Treat ; 181(3): 679-689, 2020 Jun.
Article in En | MEDLINE | ID: mdl-32367460

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms / Biomarkers, Tumor / Receptor, ErbB-2 / Neoplastic Cells, Circulating Type of study: Prognostic_studies Limits: Female / Humans / Middle aged Language: En Journal: Breast Cancer Res Treat Year: 2020 Document type: Article Affiliation country: United States Country of publication: Netherlands

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms / Biomarkers, Tumor / Receptor, ErbB-2 / Neoplastic Cells, Circulating Type of study: Prognostic_studies Limits: Female / Humans / Middle aged Language: En Journal: Breast Cancer Res Treat Year: 2020 Document type: Article Affiliation country: United States Country of publication: Netherlands